Patents by Inventor Henry R. Wolfe, Jr.

Henry R. Wolfe, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS TO INHIBIT KIDNEY STONE GROWTH
    Publication number: 20210128665
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Application
    Filed: December 30, 2020
    Publication date: May 6, 2021
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, JR.
  • Compositions and methods to inhibit kidney stone growth
    Patent number: 10471115
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: November 12, 2019
    Assignee: KIDNEY STONE RESEARCH COMPANY, INC.
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, Jr.
  • COMPOSITIONS AND METHODS TO INHIBIT KIDNEY STONE GROWTH
    Publication number: 20180008660
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Application
    Filed: September 20, 2017
    Publication date: January 11, 2018
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, Jr.
  • Compositions and methods to inhibit kidney stone growth
    Patent number: 9789152
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: October 17, 2017
    Assignee: KIDNEY STONE RESEARCH COMPANY, INC.
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, Jr.
  • COMPOSITIONS AND METHODS TO INHIBIT KIDNEY STONE GROWTH
    Publication number: 20170216388
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Application
    Filed: April 14, 2017
    Publication date: August 3, 2017
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, JR.
  • Compositions and methods to inhibit kidney stone growth
    Patent number: 9623066
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: April 18, 2017
    Assignee: KIDNEY STONE LABORATORIES, INC.
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, Jr.
  • COMPOSITIONS AND METHODS TO INHIBIT KIDNEY STONE GROWTH
    Publication number: 20170065657
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 9, 2017
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, JR.
  • COMPOSITIONS AND METHODS TO INHIBIT KIDNEY STONE GROWTH
    Publication number: 20170065658
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Application
    Filed: September 15, 2016
    Publication date: March 9, 2017
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, JR.
  • Compositions and methods to inhibit kidney stone growth
    Patent number: 9492491
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: November 15, 2016
    Assignee: KIDNEY STONE LABORATORIES, INC.
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, Jr.
  • Compositions and methods to inhibit kidney stone growth
    Patent number: 9233135
    Abstract: An oral dosage form or plurality of oral dosage forms comprising as active ingredients citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: January 12, 2016
    Assignee: KIDNEY STONE LABORATORIES, INC.
    Inventors: Gregory K. Hayer, Brendan Magrab, Henry R. Wolfe, Jr.
  • Apparatus for processing fluids
    Patent number: 4775629
    Abstract: A cartridge is formed of two parts which form an outlet valve at the lower end. The valve is opened or closed by relative rotation of the parts.
    Type: Grant
    Filed: May 5, 1987
    Date of Patent: October 4, 1988
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Ernest B. Kuhl, George R. Long, Juleen A. Mitchell, Richard S. Jenkins, Henry R. Wolfe, Jr., Gerard F. Malone